semaglutide news october 26 2025 Semaglutide 2.4 mg Clinical Outcomes in Patients with Obesity or Overweight: A Real-World Retrospective Comparative Cohort Study Democratic lawmakers are pressing the
Description
PlexusDx personalized therapy, informed by your genetic predisposition to GLP-1 response, can help optimize your individual timeline
Many patients begin with standard labs
For patients thinking about the longer arc of their treatment, the article on semaglutide to tirzepatide switching guide covers what that transition looks like clinically and what to expect during the process
Since the gut and vaginal microbiomes are often linked, a major shift in one can sometimes impact the other
Before starting: GLP-1 drugs carry an FDA boxed warning for thyroid C-cell tumors observed in rodent studies
